Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bintrafusp Alfa in MSI-H Solid Tumors and CMS4 Colorectal Cancer
NCT03436563Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2018
- Primary completion
- Aug 2023
- Countries
- 1
01
Overview
A Phase 2 trial of bintrafusp alfa in colorectal cancer (CRC), solid tumor, sponsored by University of Texas MD Anderson Cancer Center. Started Mar 2018; status: completed.
02
Drugs
bintrafusp alfa
03
Conditions
colorectal cancer (CRC)solid tumor
Beyond the preview
Go deeper on NCT03436563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03436563.